Affinity purification–mass spectrometry (AP-MS) reports bait-centered co-enrichment after a defined capture and liquid chromatography–tandem mass spectrometry (LC-MS/MS). It does not return a validated interaction network. A protein name in the bait eluate is identification. Enrichment against a matched control is a stronger, still provisional, candidate. Direct binding is a later assay.
The original three evidence levels remain the useful split. They are not interchangeable in a figure caption. Detecting a prey in one purification is weaker than reproducible enrichment against an empty-tag, bead-only, isotype, or unrelated-bait arm. Enrichment is still weaker than reciprocal capture, domain dependence, or a pairwise binding measurement. For how a scored file is read after those arms exist, How to Analyze IP Mass Spectrometry Results? provides a complementary analysis-order page.
Researchers who already have a bait format and need a ranked co-enrichment table can also review the MtoZ Biolabs Affinity Purification-Mass Spectrometry Service for project-specific feasibility and analysis planning.
What the Enrichment Experiment Writes
AP-MS results are produced by the bait, the capture chemistry, and the comparison. They are not a context-free protein list.
Bait format decides which protein entered the tube. A tagged construct, an endogenous antibody capture, and an immobilized recombinant bait do not share an interpretation. A prey that follows an overexpressed tag may not follow the endogenous protein. For how antibody capture is coupled to the spectrometer, How to Combine Co-IP with Mass Spectrometry for Protein Interaction Analysis? provides a complementary capture page.
Wash and lysis decide which associations survive. Mild detergent keeps more candidates and more background. A harsher wash can drop a weak or transient partner. A missing protein can be dissociation during washing. It is not biological absence.
Control design decides whether enrichment is bait-specific. Empty-tag, bead-only, isotype, and unrelated-bait arms define different backgrounds. Without that contrast, abundant contaminants are easy to name as interactors. For the control menu on antibody and in-cell work, What Controls Are Needed for Co-IP-MS and In-Cell Crosslinking MS? provides a complementary control page.
Comparison structure decides whether a treatment or mutant sentence is allowed. All arms must use the same capture chemistry. Uneven bait recovery can create a false differential edge.
Figure 1. Identification is peptides in the eluate. Enrichment is recovery above a matched control. Direct binding is not this file.
Read the enrichment experiment before reading the protein names. A spreadsheet of associated proteins is not an interactome.
Claim Types the Original Table Still Filters
The original claim filter stays. AP-MS can support discovery-stage language. It cannot support a binding-mechanism figure without follow-up.
Claim type |
Typical AP-MS support |
Common overreach |
|---|---|---|
Protein detected in bait eluate |
Identification only |
Every detection is an interactor |
Bait-specific enrichment versus control |
Supported when controls and replicates match |
Ignoring empty-tag or bead background |
Condition-dependent co-enrichment |
Supported when capture chemistry matches across arms |
Treating bait-recovery differences as biology |
Direct binary binding |
Not supported |
All co-enriched proteins are direct binders |
Functional coupling in cells |
Not supported |
Pathway activity from one bait list |
Stable complex membership |
Partial, and only as co-recovery |
One purification is a permanent complex |
The same dataset can nominate a shortlist and still be insufficient for a contact or a function. For the wet order that produced the eluate, Process of IP Mass Spectrometry provides a complementary process page.
Bait recovery is checked first. Low or uneven bait in one arm weakens every prey sentence tied to that purification. Presence in the bait sample is not enrichment. Fold change, a scoring method such as SAINT, or an equivalent rank changes which names are defensible. A literature contaminant list and the project’s own control distribution both matter. A protein can be identified and still fail as a candidate. Do not subtract every control identification. Rank specificity.
Figure 2. Bait format, wash stringency, control class, and matched arms. The list is read from that design, not as a map.
Misreads That Recur
Calling every identified protein a validated interactor ignores the control and the replicate. Equating co-enrichment with direct binding ignores indirect complex members and bead binders that survived the wash. Treating the list as in-cell contact sites conflates recovery with spatial evidence.
One bait list cannot support broad pathway remodeling. Background proteins in a strong list are expected. Interpretation is ranking, not a demand for a clean eluate. Dismissing the file because contaminants appear is the complementary error.
Orthogonal work is chosen from the next claim, not added as cleanup. Reciprocal Co-IP or a pull-down tests whether the prey can return the bait. Domain or mutation mapping tests whether enrichment depends on a named surface. Surface plasmon resonance or biolayer interferometry can support a direct pair that AP-MS cannot. Proximity labeling or crosslinking MS is a different table when the association is poorly retained in a standard wash. Discovery can stop at a ranked shortlist. A mechanism sentence should have that follow-up named before the first capture when possible.
Figure 3. Keep: bait-centered enrichment and a ranked candidate list. Not granted: every ID as an interactor, direct binding, or contact sites.
Experimental Limits
Understanding AP-MS reduces a project to one bait, one capture, one control class, and one claim level. Diagnostic network or drug-target language sits outside ordinary research reporting unless a separately validated assay is in place.
Project Planning and Service Scope
A usable plan names the bait format, the matched control, the claim that the table is allowed to support, and the orthogonal assay that would be required for the next sentence, before the first lysate is bound. MtoZ Biolabs scopes AP-MS and related capture-MS on Orbitrap-class LC-MS/MS. Interpretability still follows those arms, not a comprehensive-guide slogan.
Once the next sentence is a reciprocal or endogenous antibody pellet rather than a tagged discovery list, the project is no longer this guide. Researchers who need that pellet can review the MtoZ Biolabs Co-IP-MS Protein Interaction Analysis Service for project-specific sample evaluation, feasibility assessment, and workflow planning.
Frequently Asked Questions
1. Does AP-MS prove protein-protein interactions?
No. It shows co-enrichment under defined capture conditions. Direct binding is a later assay.
2. Why do strong AP-MS lists still contain background proteins?
Beads, tags, and abundant lysate proteins co-purify. Rank against matched controls. Do not expect a background-free list.
3. Can AP-MS results be compared across treatment groups?
Yes, when bait recovery, capture chemistry, and analysis depth match across arms. Uneven bait recovery can invent a condition effect.
4. How should AP-MS candidates be prioritized?
Reproducible enrichment over controls first. Annotation is last. A single-run detection without contrast stays off the shortlist.
5. Does AP-MS map contact sites?
No. Recovery is not spatial or structural evidence.
Reference
- Gingras A.C., Gstaiger M., Raught B., Aebersold R. (2007). Analysis of protein complexes using mass spectrometry. Nat. Rev. Mol. Cell Biol., 8, 645-654. https://doi.org/10.1038/nrm2208
- Choi H., Larsen B., Lin Z.Y., et al. (2011). SAINT: probabilistic scoring of affinity purification-mass spectrometry data. Nat. Methods, 8, 70-73. https://doi.org/10.1038/nmeth.1541
- Mellacheruvu D., Wright Z., Couzens A.L., et al. (2013). The CRAPome: a contaminant repository for affinity purification-mass spectrometry data. Nat. Methods, 10, 730-736. https://doi.org/10.1038/nmeth.2557
- Nesvizhskii A.I. (2012). Computational and informatics strategies for identification of specific protein interaction partners in affinity purification mass spectrometry experiments. Proteomics, 12, 1639-1655. https://doi.org/10.1002/pmic.201100537
- Huttlin E.L., Ting L., Bruckner R.J., et al. (2015). The BioPlex network: a systematic exploration of the human interactome. Cell, 162, 425-440. https://doi.org/10.1016/j.cell.2015.06.043
